These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2031311)
1. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct]. Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311 [TBL] [Abstract][Full Text] [Related]
2. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873 [TBL] [Abstract][Full Text] [Related]
3. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase. Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267 [TBL] [Abstract][Full Text] [Related]
4. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction. Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862 [TBL] [Abstract][Full Text] [Related]
5. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction. Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947 [TBL] [Abstract][Full Text] [Related]
6. Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen. Seifried E; Oethinger M; Tanswell P; Hoegee-de Nobel E; Nieuwenhuizen W Thromb Haemost; 1993 Apr; 69(4):321-7. PubMed ID: 8497843 [TBL] [Abstract][Full Text] [Related]
7. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy]. Kobusiak-Prokopowicz M; Mysiak A Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the effectiveness of streptokinase in acute myocardial infarct with respect to the pump function of the heart]. Duraković Z; Smalcelj A; Radonić R; Ivanović D; Gasparović V; Gjurasin M; Bosnić D; Ljubojević B; Bogdan I; Grgić V Acta Med Iugosl; 1990; 44(3):185-96. PubMed ID: 2396487 [TBL] [Abstract][Full Text] [Related]
9. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA]. De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587 [TBL] [Abstract][Full Text] [Related]
10. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery. Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932 [TBL] [Abstract][Full Text] [Related]
11. [Thrombolytic therapy of acute myocardial infarct in a district hospital. Analysis of a group of patients treated with streptokinase]. Baraniková D; Renker B; Augustín E; Brunclík P Vnitr Lek; 1993 Mar; 39(3):260-5. PubMed ID: 8506678 [TBL] [Abstract][Full Text] [Related]
12. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)]. Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865 [TBL] [Abstract][Full Text] [Related]
13. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity]. Kharash LM; Goldkhammer EI Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192 [TBL] [Abstract][Full Text] [Related]
14. [Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct]. Cassin M; Charmet PA; Rellini G; Molaro G; Bitto S; Brieda M; Zanuttini D G Ital Cardiol; 1987 Jul; 17(7):601-4. PubMed ID: 3678711 [TBL] [Abstract][Full Text] [Related]
15. [Changes in hemocoagulation during thrombolytic therapy of acute myocardial infarct in relation to risks of thrombotic complications]. Kessler P; Kubícková M Vnitr Lek; 1994 Jun; 40(6):354-8. PubMed ID: 8073644 [TBL] [Abstract][Full Text] [Related]
16. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction. French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675 [TBL] [Abstract][Full Text] [Related]
18. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase. Salvioni A; Marenzi GC; Agostoni P; Grazi S; Guazzi MD Eur Heart J; 1994 May; 15(5):654-9. PubMed ID: 8056006 [TBL] [Abstract][Full Text] [Related]
19. Biochemical changes noted during intermittent administration of streptokinase. Verstraete M; Vermylen J; Schetz J Thromb Haemost; 1978 Feb; 39(1):61-8. PubMed ID: 148118 [TBL] [Abstract][Full Text] [Related]
20. Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction. Lew AS; Berberian L; Cercek B; Lee S; Shah PK; Ganz W J Am Coll Cardiol; 1986 Jun; 7(6):1320-4. PubMed ID: 3711489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]